Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of eplerenone in systolic dysfunction complicating acute myocardial infarction heart failure patients

Trial Profile

Effect of eplerenone in systolic dysfunction complicating acute myocardial infarction heart failure patients

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 21 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Cardiovascular disorders; Heart failure; Left ventricular dysfunction; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms EPHESUS
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Apr 2022 Results assessing Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure published in the Clinical Research in Cardiology
    • 02 Mar 2020 Results of myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction has been published in the European Heart Journal
    • 05 Nov 2010 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top